Glory Health Industry Valuation
Is 2329 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2329 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2329 (HK$0.14) is trading above our estimate of fair value (HK$0)
Significantly Below Fair Value: 2329 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2329?
Key metric: As 2329 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 2329's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | CN¥2.04b |
| Market Cap | CN¥567.84m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 12.3x |
| Enterprise Value/EBITDA | -275.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2329's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.1x | ||
367 Chuang's Consortium International | 1.5x | n/a | HK$593.8m |
627 Japan Kyosei Group | 5.7x | n/a | HK$738.8m |
618 Peking University Resources (Holdings) | 0.2x | n/a | HK$347.7m |
120 Cosmopolitan International Holdings | 0.9x | n/a | HK$320.1m |
2329 Glory Health Industry | 0.3x | n/a | HK$608.9m |
Price-To-Sales vs Peers: 2329 is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (2.1x).
Price to Sales Ratio vs Industry
How does 2329's PS Ratio compare vs other companies in the HK Real Estate Industry?
Price-To-Sales vs Industry: 2329 is good value based on its Price-To-Sales Ratio (0.3x) compared to the Hong Kong Real Estate industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is 2329's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 2329's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
C&D International Investment Group
HK$25.3b
An investment holding company, engages in the property development, real estate industry chain investment services, and industry investment activities in Mainland China, Hong Kong, Macau, Taiwan, and internationally.
1908
HK$12.56
7D
-11.3%
1Y
-24.6%
C&D International Investment Group
HK$25.3b
An investment holding company, engages in the property development, real estate industry chain investment services, and industry investment activities in Mainland China, Hong Kong, Macau, Taiwan, and internationally.
1908
HK$13.00
7D
-7.1%
1Y
-18.3%
Poly Property Group
HK$6.0b
An investment holding company, engages in the property investment, development, and management business in Hong Kong, the People’s Republic of China, and internationally.
119
HK$1.57
7D
-3.7%
1Y
-4.8%